Newcells Biotech (“Newcells”), a leading drug discovery partner specializing in developing in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, today announced the appointment of Emile Shaffu as Director of Sales. With over 20 years of international sales and management experience in the life sciences, his appointment is part of the Company’s commercial strategy to strengthen its position across key global markets and improve customer support. Emile joins Newcells following a series of recent appointments to the executive and US commercial teams, forming part of the Company’s strategy for further expansion and technological innovation 1 .
In his new role, Emile will lead the international sales strategy, building on the team's rapid growth and commercial success in the past year. His appointment will provide further support for Newcells’ global network, demonstrating an ongoing commitment to customer service and meeting increasing market demand for new approach methods (NAMs) in drug discovery. Emile brings a wealth of commercial and technical expertise spanning molecular biology and cutting-edge genomic technologies, with a proven track-record in developing successful sales strategies and driving the adoption of innovative scientific solutions.
Most recently as UK Regional Business Manager at Californian-based Bionano Genomics, he spearheaded the successful introduction of the Company’s novel optical genome mapping techn.